03/12/2025 2:33 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 9:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 6:17 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 6:20 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 5:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/06/2025 10:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/05/2025 9:52 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 9:22 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/03/2025 5:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2025 8:29 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/26/2025 5:08 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Get the Latest News and Ratings for AZN and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AstraZeneca and its competitors with MarketBeat's FREE daily newsletter.
|
02/19/2025 5:59 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 9:30 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 7:02 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/18/2025 6:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/06/2025 8:53 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/05/2025 11:15 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form EFFECT | |
02/03/2025 12:05 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/03/2025 5:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/28/2025 8:25 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/24/2025 8:52 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Cellectis S.A. (Subject)
| Form SCHEDULE 13D/A | |
01/21/2025 11:17 AM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) JPMorgan Chase Bank, N.A. - ADR Depositary (Filed by)
| Form F-6 Registration statement under the Securities Act of 1933 for depositary shares evidenced by American depositary receipts | |
01/21/2025 5:40 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/17/2025 6:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2025 9:04 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/26/2024 10:05 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/23/2024 11:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/16/2024 9:04 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2024 8:01 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 9:28 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/02/2024 9:35 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/25/2024 5:43 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2024 10:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/18/2024 5:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024 8:13 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/15/2024 5:48 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2024 11:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 6:10 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/08/2024 8:10 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/01/2024 10:46 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Lying in hospital… staring at the light (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune.
After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life |
10/28/2024 5:00 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Monopar Therapeutics (Subject)
| Form SC 13G | |
10/21/2024 8:48 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/11/2024 5:01 AM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject) CONDUIT PHARMACEUTICALS INC. (Subject)
| Form SC 13G | |
10/07/2024 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/01/2024 9:45 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/26/2024 5:42 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:44 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/23/2024 5:27 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2024 12:34 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/13/2024 9:50 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 5:05 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/16/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 9:11 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/30/2024 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/29/2024 5:00 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/26/2024 5:42 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/25/2024 8:06 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/15/2024 5:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 9:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 5:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2024 4:00 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 11-K Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/25/2024 5:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/25/2024 5:07 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/18/2024 5:38 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 5:21 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/12/2024 9:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/04/2024 9:02 AM | AstraZeneca (Subject) ASTRAZENECA PLC (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/03/2024 9:23 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 9:29 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/03/2024 5:35 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 5:15 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/21/2024 5:08 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/20/2024 5:32 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/16/2024 5:41 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/15/2024 9:09 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 6:31 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/02/2024 5:49 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 6:18 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/29/2024 5:52 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 5:26 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 12:22 PM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/11/2024 5:55 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 5:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 5:14 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024 5:22 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 7:45 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/02/2024 6:54 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/25/2024 6:28 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/19/2024 4:27 PM | AstraZeneca (Filed by) ASTRAZENECA PLC (Filed by) Fusion Pharmaceuticals Inc. (Subject)
| Form DFAN14A | |
Lying in hospital… staring at the light (Ad) "Please don’t die on me," the nurse begged as Porter Stansberry lay in a hospital bed, his heart stopped from years of pushing himself too hard. At his lowest point, he realized that everything had gone wrong, and he was forced to rebuild—not just his health, but his entire life and fortune.
After clawing his way out of that abyss, Porter discovered a life-changing investment strategy, one that allowed him to rebuild his wealth far faster and with less risk than he ever imagined. This approach helped him earn enormous returns outside of the volatile stock market, and now he’s sharing it with you. While most won’t believe it’s possible, Porter is asking you to open your mind and consider a new way of investing—one that could transform your financial future, just as it did for him. [Click here] to learn more about this powerful strategy and discover your own financial "Second Life |
03/19/2024 3:31 PM | AstraZeneca Finance LLC (Filer) AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form F-3ASR | |
03/19/2024 5:02 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/14/2024 6:12 AM | AstraZeneca (Filer) ASTRAZENECA PLC (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |